Novartis Investigative Site

Tochigi 329-0498

0 studies enrolling now · 2 studies all time

What they study most

Non-Hodgkin's Lymphoma, Uveitis

Studies at this site

• Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis — Withdrawn before enrolling
• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early